Inactief instrument

Koers Anacor Pharmaceuticals Inc

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Anacor Pharmaceuticals : received rival bid before Pfizer deal - filing	26-05-16
Ryan & Maniskas, LLP : Announces Investigation of Anacor Pharmaceuticals, Inc.	18-05-16
Brower Piven Commences an Investigation into the Proposed Sale of Anacor Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information	17-05-16
Brower Piven Commences an Investigation into the Proposed Sale of Anacor Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information	16-05-16
Anacor Pharmaceuticals : Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel	16-05-16

Managers	Titel	Leeftijd	Van
Douglas Giordano CEO	Chief Executive Officer	61	24-06-16
Jacob John Plattner CTO	Chief Tech/Sci/R&D Officer	77	01-02-04
Margaret M. Madden BRD	Director/Board Member	-	24-06-16

Besturend	Titel	Leeftijd	Van
Douglas Giordano CEO	Chief Executive Officer	61	24-06-16
Bryan Supran BRD	Director/Board Member	-	24-06-16
Margaret M. Madden BRD	Director/Board Member	-	24-06-16

Sector

	Vaira. 1 jan.	Kapi.
IQVIA HOLDINGS INC.	+1,51%	42,75 mld.
LONZA GROUP AG	+49,22%	41,61 mld.
MODERNA, INC.	+8,57%	41,34 mld.
CELLTRION, INC.	-12,36%	26,59 mld.
ICON PUBLIC LIMITED COMPANY	+8,92%	25,49 mld.
ALNYLAM PHARMACEUTICALS, INC.	-25,13%	18,12 mld.
MEDPACE HOLDINGS, INC.	+29,17%	12,24 mld.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,12%	11,76 mld.
UNITED THERAPEUTICS CORPORATION	+6,35%	11 mld.